BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/14/2022 12:54:50 PM | Browse: 259 | Download: 795
 |
Received |
|
2022-06-08 16:16 |
|
Peer-Review Started |
|
2022-06-08 16:19 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-08-20 14:56 |
|
Revised |
|
2022-09-04 09:30 |
|
Second Decision |
|
2022-09-13 03:47 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-09-14 16:44 |
|
Articles in Press |
|
2022-09-14 16:44 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-09-27 15:57 |
|
Publish the Manuscript Online |
|
2022-10-14 12:54 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Combining of chemotherapy with targeted therapy for advanced biliary tract cancer: A systematic review and meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xue-Song Bai, Sheng-Nan Zhou, Yi-Qun Jin and Xiao-Dong He |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| China Academy of Medical Science Innovation Fund for Medical Sciences, CIFMS |
2021-I2M-1-022-2021-S4 |
|
| Corresponding Author |
Xiao-Dong He, Doctor, MD, Professor, Department of General Surgery, Peking Union Medical College Hospital, China Academy of Medical Science & Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China. hxdpumch@163.com |
| Key Words |
Advanced biliary tract cancer; Targeted therapy; Chemotherapy; Meta-analysis; Randomized controlled trial; First-line treatment |
| Core Tip |
The clinical efficacy of adding targeted agents to first-line treatment of biliary tract cancer (BTC) remains unclear. Our study is the first meta-analysis of randomized clinical trials to evaluate the efficacy of the combination of targeted therapy (TT) with standard chemotherapy (CT) as first-line treatment in patients with advanced BTC. We assessed the efficacy of combined TT and CT in terms of objective response rate, progression-free survival and overall survival. Subgroup analyses were conducted based on different targeted agents, CT regimens and tumor locations. |
| Publish Date |
2022-10-14 12:54 |
| Citation |
Bai XS, Zhou SN, Jin YQ, He XD. Combining of chemotherapy with targeted therapy for advanced biliary tract cancer: A systematic review and meta-analysis. World J Gastrointest Oncol 2022; 14(10): 2061-2076 |
| URL |
https://www.wjgnet.com/1948-5204/full/v14/i10/2061.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v14.i10.2061 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
